UCB's Global Corporate Website
Welcome to UCB in the United States

May

23

Supporting STEM in North Carolina

Wake County, NC teachers visiting for UCB’s annual SummerSTEM day. (L to R) Andrew Oliver, Bruce Mamel, Michelle Woods, Sarah Brown, Ken Whisler, Cherilyn Murray, Antwanna Pegues Simmons, and Laura Williford.

At UCB, we are committed to accelerating scientific discoveries by supporting innovation — leading to the discovery of new solutions that help patients achieve their goals. As part this commitment, we believe it is important to support STEM education in our local communities to help inspire the next generation of scientists.

May

20

Press Release: UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

May

12

New Open Innovation Challenge to Rethink Post-Fracture Care

This Osteoporosis Awareness Month, UCB is pleased to collaborate with OpenIDEO , an open innovation platform, to launch the new Healthy Bones, Healthy Aging Challenge.

May

10

AGA IBD Parenthood Project provides guidance about pregnancy for women with IBD and their health care team

A key underserved patient population is women of childbearing age managing chronic conditions. In honor of Mother’s Day, Aimee Frank, Senior Director of Communications at the American Gastroenterological Association (AGA), shares about the IBD Parenthood Project, an effort led by the AGA with support by UCB, to help address the misperceptions women with inflammatory bowel disease and their healthcare providers experience throughout family planning.

May

03

Disease Spotlight: Non-Radiographic Axial Spondyloarthritis

UCB is committed to improving care and outcomes for patients across the axial spondyloarthritis spectrum of disease. So, for Spondyloarthritis Awareness Month, we’re shining a spotlight on Non-Radiographic Axial Spondyloarthritis (nr-axSpA).

May

02

UCB Flies in to DC to Advocate for Innovation

Earlier this week, researchers from across UCB met in Washington, D.C. for the PhRMA Researcher Fly-In. While on Capitol Hill, the UCB team visited the offices of Representatives Doug Collins, Lucy McBath, and David Price, and Senators Johnny Isakson, Richard Burr, and Thom Tillis and walked their staff through the 15-year journey (on average) of how a new medicine is discovered, developed, and delivered at UCB. Each researcher, representing a different part of the drug development process, shared their personal stories about why they’re motivated each day to continue to innovate for patients.